CÁNCER DE MAMA
![Foto de CÁNCER DE MAMA](/img/grupo.png)
![Foto de Hospital San Pedro de Alcántara](/img/noimage_org.png)
Hospital San Pedro de Alcántara
Cáceres, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital San Pedro de Alcántara (2)
2024
-
Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study
Breast, Vol. 77
-
Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer
JAMA network open, Vol. 7, Núm. 4, pp. e247811